首页> 外文期刊>Endocrinology >The PTTG1-binding factor (PBF/PTTG1IP) regulates p53 activity in thyroid cells
【24h】

The PTTG1-binding factor (PBF/PTTG1IP) regulates p53 activity in thyroid cells

机译:PTTG1结合因子(PBF / PTTG1IP)调节甲状腺细胞中的P53活性

获取原文
获取原文并翻译 | 示例
           

摘要

The PTTG1-binding factor (PBF/PTTG1IP) has an emerging repertoire of roles, especially in thyroid biology, and functions as a protooncogene. High PBF expression is independently associated with poor prognosis and lower disease-specific survival in human thyroid cancer. However, the precise role of PBF in thyroid tumorigenesis is unclear. Here, we present extensive evidence demonstrating that PBF is a novel regulator of p53, a tumor suppressor protein with a key role in maintaining genetic stability, which is infrequently mutated in differentiated thyroid cancer. By coimmunoprecipitation and proximity-ligation assays, we show that PBF binds specifically to p53 in thyroid cells and significantly represses transactivation of responsive promoters. Further, we identify that PBF decreases p53 stability by enhancing ubiquitination, which appears dependent on the E3 ligase activity of Mdm2. Impaired p53 function was evident in a transgenic mouse model with thyroid-specific PBF overexpression (transgenic PBF mice), which had significantly increased genetic instability as indicated by fluorescent inter simple sequence repeat-PCR analysis. Consistent with this, approximately 40% of all DNA repair genes examined were repressed in transgenic PBF primary cultures, including genes with critical roles in maintaining genomic integrity such as Mgmt, Rad51, and Xrcc3. Our data also revealed that PBF induction resulted in up-regulation of the E2 enzyme Rad6 in murine thyrocytes and was associated with Rad6 expression in human thyroid tumors. Overall, this work provides novel insights into the role of the protooncogene PBF as a negative regulator of p53 function in thyroid tumorigenesis, in which PBF is generally overexpressed and p53 mutations are rare compared with other tumor types.
机译:PTTG1结合因子(PBF / PTTG1IP)具有出现的作用的作用,特别是在甲状腺生物学中,并用作原毒胞基因。高PBF表达与人甲状腺癌中的预后差和疾病特异性存活率无关。然而,PBF在甲状腺肿瘤中的确切作用尚不清楚。在这里,我们呈现广泛的证据证明PBF是P53的新调节剂,一种肿瘤抑制蛋白,具有在维持遗传稳定性的关键作用,在分化的甲状腺癌中罕见突变。通过CoimMunopropipIpitipitation和邻近连接测定,我们表明PBF特异性结合甲状腺细胞中的P53,并显着抑制响应促进剂的转移。此外,我们认为PBF通过增强泛素化来降低P53稳定性,这依赖于MDM2的E3连接酶活性。在具有甲状腺特异性PBF过表达(转基因PBF小鼠)的转基因小鼠模型中,P53功能在转基因小鼠模型中是显而易见的,其如荧光性跨性序列重复PCR分析所示显着增加了遗传不稳定。符合此,在转基因PBF原发性培养物中抑制了所检查的所有DNA修复基因的约40%,包括在维持基因组完整性如MgMT,Rad51和XRCC3中具有关键作用的基因。我们的数据还显示出PBF诱导导致鼠氰基中的E2酶RAD6的上调,并与人甲状腺肿瘤中的RAD6表达相关。总的来说,这项工作为原毒丙烯PBF作为P53功能的负调节剂的角色提供了新的洞察,其中PBF通常过表达,与其他肿瘤类型相比,P53突变是罕见的。

著录项

  • 来源
    《Endocrinology》 |2014年第4期|共13页
  • 作者单位

    School of Clinical and Experimental Medicine Institute of Biomedical Research University of;

    School of Clinical and Experimental Medicine Institute of Biomedical Research University of;

    School of Clinical and Experimental Medicine Institute of Biomedical Research University of;

    School of Clinical and Experimental Medicine Institute of Biomedical Research University of;

    School of Clinical and Experimental Medicine Institute of Biomedical Research University of;

    School of Clinical and Experimental Medicine Institute of Biomedical Research University of;

    Department of Medical Sciences University of Ferrara Ferrara Italy;

    School of Clinical and Experimental Medicine Institute of Biomedical Research University of;

    Department of Pediatrics University of British Columbia Vancouver BC Canada;

    School of Clinical and Experimental Medicine Institute of Biomedical Research University of;

    School of Clinical and Experimental Medicine Institute of Biomedical Research University of;

    School of Clinical and Experimental Medicine Institute of Biomedical Research University of;

    University Hospitals Birmingham National Health Service Foundation Trust Birmingham United Kingdom;

    School of Clinical and Experimental Medicine Institute of Biomedical Research University of;

    School of Clinical and Experimental Medicine Institute of Biomedical Research University of;

    School of Cancer Sciences University of Birmingham Birmingham United Kingdom;

    School of Clinical and Experimental Medicine Institute of Biomedical Research University of;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 内分泌腺疾病及代谢病;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号